Immediate Impact

2 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Organoids: The current status and biomedical applications
2023 Standout
Endocytosis in cancer and cancer therapy
2023 Standout
2 intermediate papers

Works of P. Schöffski being referenced

European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy
2018
A phase I pharmacokinetic (PK) and molecular pharmacodynamic (PD) study of the combination of two anti-EGFR therapies, the monoclonal antibody (MAb) cetuximab (C) and the tyrosine kinase inhibitor (TKI) gefitinib (G), in patients (pts) with advanced colorectal (CRC), head and neck (HNC) and non-small cell lung cancer (NSCLC)
2006

Author Peers

Author Last Decade Papers Cites
P. Schöffski 178 96 18 144 128 14 390
John DeLuca 70 100 70 225 80 9 362
T. Christopher Windham 178 110 35 203 43 14 435
Alba Mineo 110 48 42 207 97 13 442
Ignacio Wistuba 193 144 71 179 57 20 414
Heejin Bang 142 93 100 214 58 21 399
Bos Jl 118 44 53 256 34 13 389
Ciarán Ó’Riain 150 73 85 83 74 16 386
Ruud van der Noll 208 98 59 315 49 20 456
W. ten Bokkel Huinink 148 49 17 85 185 17 403
Juliane Friemel 146 76 127 141 53 17 446

All Works

Loading papers...

Rankless by CCL
2026